2026年11月2日星期一
M
Rekod Semesta
Berita Pantas Global
Surging costs and China trade war test US farmers' loyalty to Trump— 日经 Nikkei AsiaBangladesh turns to China for worker training amid graduate job struggles— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaOriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaSurging costs and China trade war test US farmers' loyalty to Trump— 日经 Nikkei AsiaBangladesh turns to China for worker training amid graduate job struggles— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaOriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei Asia

Milestone cancer vaccine success leaves hard questions unanswered

Sumber Science 科学7 hari lalu
Ringkasan kandungan

mRNA vaccine from Merck and Moderna slashes risk of melanoma’s return, but why remains unclear

Laman ini hanya menyediakan indeks tajuk dan ringkasan, kandungan penuh dan hak cipta adalah milik pihak penerbit asal, sila klik pautan asal untuk membaca.

Pergi ke artikel asal
Saluran berkaitan
Sains
Kawasan berkaitan
Amerika
Bahasa teks asal
English
Nombor entri
science-dddec3cf

Comments 0 comments

No comments yet. Be the first.

Milestone cancer vaccine success leaves hard questions unanswered · Rekod Semesta